Delivery Order SPE2DB22D2007-SPE2DB25FJ2SR
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,514.35 firm-fixed-price delivery order is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. The contract has an ultimate completion date of May 30, 2025 and is not set-aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,581.86 delivery order contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product. The contract is a Firm Fixed Price, non-set-aside award with a completion date of June 11, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,149.12 firm fixed-price delivery order is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty medication. The contract has an ultimate completion date of March 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,043.90 firm-fixed-price delivery order is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product. The contract has an ultimate completion date of October 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is a delivery order with a ceiling value of $31,406.85 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, with a period of performance through May 5, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This federal contract award, valued at $12,167.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the pharmaceutical product COSENTYX SNRDY 300MG DOSE-2PENML, with a performance period ending on May 14, 2025. The contract is a firm fixed-price arrangement and is not set aside for any particular business category. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,957.12 delivery order contract is for the supply of the drug COSENTYX SNRDY 300MG DOSE-2PENML. The contract has a firm fixed price pricing type and an ultimate completion date of January 29, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $76,271.02, is a delivery order for the supply of COSENTYX 300 MG DOSE-2 SYRINGEML. The contract has a firm fixed price pricing type and an ultimate completion date of August 8, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $56,219.54, is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type. The contract has an ultimate completion date of April 10, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a $7,398.50 Firm Fixed Price Delivery Order, is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product. The contract has an ultimate completion date of June 30, 2025 and is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ2SRDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for COSENTYX 300 MG DOSE-2 SYRINGEML, with a ceiling value of $66,338.76 and a period of performance ending on July 2, 2025. The contract is designated as a firm-fixed-price, non-set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime contract, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $66.3k | 7/1/25 |